PAUL STRECK

Insider Reports History

Location
Boston, MA
Signature
/s/ Noel Donnelly, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PAUL STRECK:

Company Role Class Num Shares Value Price $ Report Date Ownership
PepGen Inc. EVP, Head of R&D Common Stock 27,805 $34,506 $1.24 30 May 2025 Direct
PepGen Inc. EVP, Head of R&D Stock Option (Right to Buy) 242,816 04 Nov 2025 Direct
ALBIREO PHARMA, INC. Chief Medical Officer Restricted Stock Units 0 02 Mar 2023 Direct

Insider Reports Filed by PAUL STRECK

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PEPG PepGen Inc. 04 Nov 2025 4 $0 4 EVP, Head of R&D 18 Dec 2025, 15:33
PEPG PepGen Inc. 30 May 2025 1 $10,393 4 EVP, Head of R&D 02 Jun 2025, 17:03
PEPG PepGen Inc. 03 Mar 2025 2 $0 4 EVP, Head of R&D 05 Mar 2025, 17:30
PEPG PepGen Inc. 19 Aug 2024 2 $0 4 EVP, Head of R&D 20 Aug 2024, 16:28
PEPG PepGen Inc. 19 Aug 2024 0 $0 3 EVP, Head of R&D 20 Aug 2024, 16:18
ALBO ALBIREO PHARMA, INC. 02 Mar 2023 1 $0 4 Chief Medical Officer 02 Mar 2023, 15:57
ALBO ALBIREO PHARMA, INC. 19 Jan 2023 1 $0 4/A Chief Medical Officer 27 Jan 2023, 16:23
ALBO ALBIREO PHARMA, INC. 19 Dec 2022 1 $0 4 Chief Medical Officer 21 Dec 2022, 15:10
ALBO ALBIREO PHARMA, INC. 19 Dec 2022 0 $0 3 Chief Medical Officer 21 Dec 2022, 15:05